To investigate the possible association between rs3480 and rs16835198 of the fibronectin type III domain containing 5 (FNDC5)/Irisin and their haplotypes with the presence of type 2 diabetes mellitus (T2DM) in Maya-Mestizo women.
Methods:
We studied 547 postmenopausal women of Maya-Mestizo origin. The diagnosis of T2DM was based on the criteria of the American Diabetes Association. DNA was obtained from blood leukocytes. rs3480 and rs16835198 of FNDC5/Irisin were studied using real-time polymerase chain reaction allelic discrimination. Deviations from Hardy–Weinberg equilibrium and alleles differences, as well as genotype frequencies between groups, were assessed by χ2 tests. Using logistic regression analysis, the odds ratio and 95% confidence intervals were calculated to estimate the association between both polymorphisms of FNDC5/Irisin and the presence of T2DM. Pairwise linkage disequilibrium between polymorphisms was calculated by direct correlation r2, and haplotype analysis was conducted.
Results:
We found that the G-allele of rs3480, as well as under a dominant model, this polymorphism was significantly associated with T2DM (P = 0.028 and P = 0.003, respectively). Besides, one haplotype was associated with T2DM (P = 0.035).
Conclusions:
Our results suggest that the FNDC5/Irisin rs3480, and one haplotype formed by rs3480 and rs16835198 were associated with the risk of presenting T2DM in Maya-Mestizo women.
Get full access to this article
View all access options for this article.
References
1.
DeFronzoRA, BonadonnaRC, FerranniniE. Pathogenesis of NIDDM. A balanced overview. Diabetes Care, 1992; 15(3):318–368; doi: 10.2337/diacare.15.3.318
2.
Shamah-LevyT, Romero-MartinezM, Barrientos-GutierrezT, et al.Encuesta Nacional de Salud y Nutricion 2021 Sobre Covid-19. Resultados Nacionales. Instituto Nacional de Salud Pública: Cuernavaca, Mexico, 2022.
3.
International Diabetes Federation. The IDF Diabetes Atlas, 10th ed. 2021. Available from: https://diabetesatlas.org/idfawp/resource-files/2021/07/IDF_Atlas_10th_Edition_2021.pdf [Last accessed: May31, 2022].
4.
FranksPW, McCarthyMI. Exposing the exposures responsible for type 2 diabetes and obesity. Science, 2016; 354(6308):69–73; doi: 10.1126/science.aaf5094
5.
BrownMR, MatveyenkoAV. It's what and when you eat: An overview of transcriptional and epigenetic responses to dietary perturbations in pancreatic islets. Front Endocrinol (Lausanne), 2022; 13:842603; doi: 10.3389/fendo.2022.842603
6.
ChenM, MoranLJ, HarrisonCL, et al.Ethnic differences in response to lifestyle intervention for the prevention of type 2 diabetes in adults: A systematic review and meta-analysis. Obes Rev, 2022; 23(1):e13340; doi: 10.1111/obr.13340
7.
WillemsenG, WardKJ, BellCG, et al.The concordance and heritability of type 2 diabetes in 34,166 twin pairs from international twin registers: The discordant twin (DISCOTWIN) consortium. Twin Res Hum Genet, 2015; 18(6):762–771; doi: 10.1017/thg.2015.83
8.
PrasadRB, GroopL. Genetics of type 2 diabetes-pitfalls and possibilities. Genes (Basel), 2015; 6(1):87–123; doi: 10.3390/genes6010087
9.
XueA, WuY, ZhuZ, et al.Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes. Nat Commun, 2018; 9(1):2941; doi: 10.1038/s41467-018-04951-w
10.
BoströmP, WuJ, JedrychowskiMP, et al.A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature, 2012; 481(7382):463–468; doi: 10.1038/nature10777
11.
Roca-RivadaA, CastelaoC, SeninLL, et al.FNDC5/irisin is not only a myokine but also an adipokine. PLoS One, 2013; 8(4):e60563; doi: 10.1371/journal.pone.0060563
12.
LiuS, DuF, LiX, et al.Effects and underlying mechanisms of irisin on the proliferation and apoptosis of pancreatic β cells. PLoS One, 2017; 12(4):e0175498; doi: 10.1371/journal.pone.0175498
13.
YanoN, ZhangL, WeiD, et al.Irisin counteracts high glucose and fatty acid-induced cytotoxicity by preserving the AMPK-insulin receptor signaling axis in C2C12 myoblasts. Am J Physiol Endocrinol Metab, 2020; 318(5):E791–E805; doi: 10.1152/ajpendo.00219.2019
14.
SongR, ZhaoX, ZhangDQ, et al.Lower levels of irisin in patients with type 2 diabetes mellitus: A meta-analysis. Diabetes Res Clin Pract, 2021; 175:108788; doi: 10.1016/j.diabres.2021.108788
15.
StaigerH, BöhmA, SchelerM, et al.Common genetic variation in the human FNDC5 locus, encoding the novel muscle-derived ‘browning’ factor irisin, determines insulin sensitivity. PLoS One, 2013; 8(4):e61903; doi: 10.1371/journal.pone.0061903
16.
TangS, ZhangR, JiangF, et al.An interaction between a FNDC5 variant and obesity modulates glucose metabolism in a Chinese Han population. PLoS One, 2014; 9(11):e109957; doi: 10.1371/journal.pone.0109957
17.
BrondaniLA, BoelterG, AssmannTS, et al.Irisin-encoding gene (FNDC5) variant is associated with changes in blood pressure and lipid profile in type 2 diabetic women but not in men. Metabolism, 2015; 64(9):952–957; doi: 10.1016/j.metabol.2015.05.005
18.
Al-DaghriNM, MohammedAK, Al-AttasOS, et al.SNPs in FNDC5 (irisin) are associated with obesity and modulation of glucose and lipid metabolism in Saudi subjects. Lipids Health Dis, 2016; 15:54; doi: 10.1186/s12944-016-0224-5
19.
KhidrEG, AliSS, ElshafeyMM, et al.Association of irisin and FNDC5 rs16835198 G > T gene polymorphism with type 2 diabetes mellitus and diabetic nephropathy. An Egyptian pilot study. Gene, 2017; 626:26–31; doi: 10.1016/j.gene.2017.05.010.
20.
MetwallyM, BayoumiA, Romero-GomezM, et al.A polymorphism in the Irisin-encoding gene (FNDC5) associates with hepatic steatosis by differential miRNA binding to the 3'UTR. J Hepatol, 2019; 70(3):494–500; doi: 10.1016/j.jhep.2018.10.021
21.
Sanchis-GomarF, GaratacheaN, HeZH, et al.FNDC5 (irisin) gene and exceptional longevity: A functional replication study with rs16835198 and rs726344 SNPs. Age (Dordr), 2014; 36(6):9733; doi: 10.1007/s11357-014-9733-1
22.
Salazar-FloresJ, Zuñiga-ChiquetteF, Rubi-CastellanosR, et al.Admixture and genetic relationships of Mexican Mestizos regarding Latin American and Caribbean populations based on 13 CODIS-STRs. Homo, 2015; 66(1):44–59; doi: 10.1016/j.jchb.2014.08.005
23.
Canto-CetinaT, Rojano-MejíaD, Coral-VázquezRM, et al.Bone mineral density and fractures in postmenopausal women of Maya-Mestizo ethnic origin with different body mass indexes. Ann Hum Biol, 2021; 48(7–8):567–571; doi: 10.1080/03014460.2022.2041093
24.
Canto-CetinaT, Silva-NicanorD, Coral-VázquezRM, et al.FNDC5/Irisin polymorphisms are associated with osteopenia in postmenopausal Mayan-Mestizo women. Climacteric, 2022; 25(6):603–608; doi: 10.1080/13697137.2022.2097866
25.
American Diabetes Association. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018. Diabetes Care, 2018; 41(Suppl. 1):S13–S27; doi: 10.2337/dc18-S002
26.
BarrettJC, FryB, MallerJ, et al.Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics, 2005; 21:263–265; doi: 10.1093/bioinformatics/bth457
27.
Instituto Nacional Instituto Nacional de Estadística y Geografía (INEGI). Características de las defunciones registradas en México durante; 2021. Available from: https://www.inegi.org.mx/ [Last accessed: November1, 2022].
28.
YangZ, ChenX, ChenY, et al.Decreased irisin secretion contributes to muscle insulin resistance in high-fat diet mice. Int J Clin Exp Pathol, 2015; 8(6):6490–6497.
29.
PerakakisN, TriantafyllouGA, Fernández-RealJM, et al.Physiology and role of Irisin in glucose homeostasis. Nat Rev Endocrinol, 2017; 13(6):324–337; doi: 10.1038/nrendo.2016.221
30.
ZhengS, ChenN, KangX, et al.Irisin alleviates FFA induced β-cell insulin resistance and inflammatory response through activating PI3K/AKT/FOXO1 signaling pathway. Endocrine, 2022; 75(3):740–751; doi: 10.1007/s12020-021-02875-y.
31.
Instituto Nacional de Estadística y Geografía (INEGI). “Estadísticas a propósito del día internacional de los pueblos indígenas.” Available from: https://www.inegi.org.mx/contenidos/saladeprensa/aproposito/2022/EAP_PueblosInd22.pdf [Last accessed: November 1, 2022].
32.
YangX, NiL, SunJ, et al.Associations between rs3480 and rs16835198 gene polymorphisms of FNDC5 with type 2 diabetes mellitus susceptibility: A meta-analysis. Front Endocrinol (Lausanne), 2022; 13:946982; doi: 10.3389/fendo.2022.946982
33.
TanisawaK, TaniguchiH, SunX, et al.Common single nucleotide polymorphisms in the FNDC5 gene are associated with glucose metabolism but do not affect serum irisin levels in Japanese men with low fitness levels. Metabolism, 2014; 63(4):574–583; doi: 10.1016/j.metabol.2014.01.005
34.
FoadAM, HafezA, YoussefW, et al.Irisin expression and FNDC5 (rs3480) gene polymorphism in type 2 diabetic patients with and without CAD. Arch Physiol Biochem, 2023:1–6; doi: 10.1080/13813455.2023.2173785
35.
Juárez-VelázquezR, CantoP, Canto-CetinaT, et al.Analysis of polymorphisms in genes (AGT, MTHFR, GPIIIa, and GSTP1) associated with hypertension, thrombophilia and oxidative stress in Mestizo and Amerindian populations of México. Dis Markers, 2010; 28(5):323–331; doi: 10.3233/DMA-2010-0712
36.
BentonML, AbrahamA, LaBellaAL, et al.The influence of evolutionary history on human health and disease. Nat Rev Genet, 2021; 22(5):269–283; doi: 10.1038/s41576-020-00305-9
